● The company's attractive earnings multiples are brought to light by a P/E ratio at 9.22 for the current year.
● The company appears to be poorly valued given its net asset value.
● Given the positive cash flows generated by its business, the company's valuation level is an asset.
● Analysts covering this company mostly recommend stock overweighting or purchase.
● Analyst opinion has improved significantly over the past four months.
● Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
● The company's earnings growth outlook lacks momentum and is a weakness.
● The group shows a rather high level of debt in proportion to its EBITDA.
● The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
● Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
● The group usually releases earnings worse than estimated.